FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4780911000001109: Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18379301000001114 Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52687301000001115 Zenapax 25mg/5ml solution for infusion vials (Roche Products Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Is a Daclizumab 25mg/5mL infusion concentrate false Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has active ingredient Daclizumab true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Is a Zenapax true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has specific active ingredient Daclizumab true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Is a Daclizumab 25mg/5ml solution for infusion vials false Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Is a Daclizumab 25mg/5ml solution for infusion vials true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) 3 vial 3 x 5ml vials Is pack of False Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) 3 vial 3 x 5ml vials Has AMP True Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start